Usher Syndrome Type III (part of Ashkenazi Jewish FlexPanel)

This test is part of the Ashkenazi Jewish FlexPanel.

PrintPrint

This test is part of the Ashkenazi Jewish FlexPanel.

Disease Name 
Usher Syndrome Type III
Disease Information 

Usher syndrome type III (USH3) is characterized by progressive hearing loss and variable onset and severity of vision problems due to retinitis pigmentosa. Balance is not usually affected. USH3 is inherited in an autosomal recessive manner, and it occurs at increased frequency in the Ashkenazi Jewish population. Mutations in the CLRN1 gene have been demonstrated to contribute to USH3. CLRN1 encodes clarin-1, a transmembrane glycoprotein that is expressed in the retina, olfactory epithelium, hair cells of the Corti, and spinal ganglion cells. It is an autosomal recessive disorder. It occurs more frequently in the Ashkenazi Jewish population, where the carrier rate is 1 in 120.  Ashkenazi Jewish individuals with a negative family history who test negative for the c.459del3 (delATT), p.N48K and p.L150P mutations in CLRN1 have a revised carrier risk of 1 in 5,950.

Test Description 

Analysis of the c.459del3 (delATT), p.N48K and p.L150P mutations in CLRN1 by pyrosequencing. This test can be ordered as part of the Ashkenazi Jewish FlexPanel.  

Mutation Detection Rate 

The mutation detection rate in the Ashkenazi Jewish population is 98%.

Genes